doi: 10.3390/biomedicines10123221
The results are shown in Table 8
Emerging peptides under study may suppress appetite via brain pathways that avoid the gastric slowing responsible for common GI side effects of current GLP-1 drugs
In Section 4, we will discuss in detail the effects of gut microbial metabolites and their components on the biological barrier
We are based in Shandong, China, start from 2009,sell to Western Europe(20.00%),South America(15.00%),North America(15.00%),Eastern Europe(10.00%),Northern Europe(10.00%),Oceania(5.00%),South Asia(5.00%),Southern Europe(5.00%),Africa(5.00%),Eastern Asia(5.00%),Mid East(5.00%)
Graphical abstract was created by BioRender ( Funding Statement The author(s) declare that no financial support was received for the research, and/or publication of this article